Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

Directorate Change

17 May 2010 12:00

RNS Number : 0356M
Symphony Environmental Tech. PLC
17 May 2010
 



 

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

 ("Symphony" or the "Group")

 

RESIGNATION OF NON-EXECUTIVE DIRECTOR

 

Symphony Environmental Technologies plc announces that Hugo Swire has been appointed Minister of State for Northern Ireland in the new UK Government and has consequently resigned as Non-Executive Director, in line with the principles laid out in the Cabinet Office's Ministerial Code guidance.

 

The Board would like to thank Hugo for his contribution to the Group and wish him well in his new role.

- ends -

 

Symphony Environmental Technologies plc

Michael Laurier, CEO

Ian Bristow, FD

  Tel: 020 8207 5900

 

Allenby Capital Limited

Nick Naylor/James Reeve

 

Tel: 020 3328 5656

Threadneedle Communications

Graham Herring/Josh Royston

 

Tel: 020 7653 9850

 

NOTE TO EDITORS:

Information about Symphony:

 

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC is a world leader in Controlled-life Plastic Technology - a system that works by a process called oxo-biodegradation. The technology is branded d2w® and appears as a droplet logo on many thousands of tonnes of plastic packaging and other products.

Symphony has a diverse and growing customer-base and has established itself successfully as an international business. Products made with d2w® plastic technology can be found in more than 90 countries around the world and in many different product applications. Symphony is a member of the Oxo-biodegradable Plastics Association (www.biodeg.org), the Society for the Chemical Industry (UK), and the American Standards Organisation (ASTM). Symphony is also a member of The US Save the Plastic Bag Coalition (http://www.savetheplasticbag.com/). Symphony actively participates in the work of the British Standards Institute (BSI) and the European Standards Organisation (CEN).

Symphony has launched d2p anti-microbial plastic technology which has applications in similar markets to d2w®.

Symphony is also developing innovative waste-to-energy technology and cost-effective processes to convert tyres and other waste-streams into valuable products.

 

Symphony is listed on the AIM market of the London Stock Exchange (Symbol SYM.L) and Symphony's American Depositary Receipts ("ADR") trade in the US on the OTC market under the symbol SETPY. The ADR to 1p ordinary share ratio is 1:100 and the CUSIP is 87156K104. BNY Mellon acts as sponsored depositary for Symphony's ADR facility.

 

Further information on the Symphony Group can be found at www.d2w.net.

To see d2w plastic degrading go to: http://youtube.com/watch?v=i3TGqcpWJTM

For information about Oxo-biodegradable plastic generally see www.biodeg.org

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUPAAUPUGUM
Date   Source Headline
28th Apr 20267:00 amRNSPre-Close Trading Update
7th Apr 20267:00 amRNS-RHSAC report
23rd Mar 20267:00 amRNSDirector/PDMR dealing - Bed & ISA
18th Feb 20268:28 amRNSNew consultancy agreement and grant of options
12th Jan 20267:00 amRNS-Rd2w Biodegradable Plastic Technology
22nd Dec 20257:00 amRNSCanadian govt policy shift re. single use plastics
22nd Dec 20257:00 amRNSCanadian govt policy shift re. single use plastics
22nd Dec 20257:00 amRNSHolding(s) in Company
22nd Dec 20257:00 amRNSHolding(s) in Company
18th Dec 20252:16 pmRNSStrategic MoU Signed with Arsan Global
18th Dec 20252:16 pmRNSStrategic MoU Signed with Arsan Global
17th Dec 20253:33 pmRNSTrading and Middle East operations update
28th Nov 20257:00 amRNS-RAlignment with BB-REG-NET's Recommendations
26th Nov 202510:25 amRNSExtension to Convertible Loan Agreements
10th Nov 20257:00 amRNS-RNew product launch, South Korea
29th Oct 20257:00 amRNS-RRoyal Society Study on Ocean Biodegradable Plastic
24th Oct 20257:00 amRNS-RCEO speaks at Argus Fertiliser Conference
16th Oct 20257:00 amRNS-RSuccessful attendance at the K-Show
30th Sep 20257:00 amRNSInterim Results for 6 Months Ended 30 June 2025
26th Sep 20257:00 amRNS-RCEO Speaks at US SPE Conference
19th Sep 20254:55 pmRNSEPA Ireland update
23rd Jul 20251:53 pmRNSResult of AGM
23rd Jul 20257:00 amRNSAGM Statement
8th Jul 202510:25 amRNSUpdate on Approval from the Republic of Ireland
25th Jun 20251:49 pmRNSHolding(s) in Company
23rd Jun 202512:37 pmRNSApproval of d2w products in Ireland
18th Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
12th Jun 20257:00 amRNSPreliminary Results
11th Jun 202510:15 amRNSChange of Subscription Amount
5th Jun 20257:00 amRNSChange of Equity Subscriber
14th May 202511:50 amRNSHolding(s) in Company
8th May 202510:35 amRNSEquity Subscription
10th Apr 20259:00 amRNSExtended Scientific Study on Microplastics in Soil
9th Apr 202510:00 amRNSTransfer of Shareholding and Assignment of CLAs
11th Mar 20257:00 amRNS-RStudy Findings - No Trace of Microplastics
10th Mar 20252:21 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNS-RRuling on Biodegradable Plastic Legislation
23rd Dec 202412:39 pmRNSOption amendments & grant of options
1st Nov 202411:15 amRNSGrant of Options
9th Sep 20247:00 amRNSInterim Results for 6 Months Ended 30 June 2024
23rd Aug 20247:00 amRNSNotice of Results and Investor Presentation
28th Jun 202412:49 pmRNSResult of AGM
28th Jun 20247:00 amRNSAGM Statement
6th Jun 20243:33 pmRNSPosting of Annual Report and Notice of AGM
6th Jun 20243:29 pmRNSPreliminary Results
23rd Apr 20244:36 pmRNSHolding(s) in Company
19th Apr 202411:16 amRNSResult of GM
3rd Apr 20242:00 pmRNSDirector dealing
28th Mar 20244:23 pmRNSResult of PrimaryBid Offer
28th Mar 20242:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.